COVID GAP Accountability Report Issue 21

March 1, 2023: COVID GAP Accountability Report Issue 21

Key Changes and Insights Since Previous Report:

  • The Pandemic Fund closed their call for expressions of interest on February 24th.

    The first call for proposals is expected to be announced in early March and

    applicants will have 11 weeks to submit proposals. The Governing Board plans to

    make funding decisions in July 2023.

  • The Global Preparedness Monitoring Board has released a document outlining 3

    tests to ensure the success of key pandemic prevention, preparedness, and

    response reforms.

  • The fourth meeting of the WHO Intergovernmental Negotiating Body will run from

    February 27th to March 3rd. Discussion will focus on the zero draft of the Pandemic


  • Dr. Jean Kaseya has been selected as the first Director General of the Africa Centers

    for Disease Control.

  • David Malpass, President of the World Bank, has announced he plans to step down

    on June 30th after serving for 4 years. The United States has nominated Ajay Banga

    to serve as the next President.

  • The U.S. FDA recently authorized the first over-the-counter test that detects both

    COVID-19 and Influenza A and B.

  • A new nasal COVID-19 vaccine has been shown to reduce the risk of symptomatic

    COVID-19 cases by 86% in a recent phase 1 clinical trial.

  • The Africa Centers for Disease Control has released its first risk-ranking and

    prioritization of epidemic-prone diseases. Ebola, Cholera, and COVID-19 were found

    to have the highest epidemic potential.